A potent Nrf2 activator, dh404, bolsters antioxidant capacity in glial cells and attenuates ischaemic retinopathy

In conclusion, agents such as dh404 that reduce oxidative stress and promote antioxidant capacity offer a novel approach to lessen the vascular and glial cell damage that occurs in ischemic retinopathies.

Source: Clinical Science - March 21, 2016 Category: Biomedical Science Authors: Deliyanti, D., Lee, J. Y., Petratos, S., Meyer, C., Ward, K., Wilkinson-Berka, J. L., de Haan, J. B. Tags: PublishAheadOfPrint Source Type: research